UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Earlier deployment of ARPIs, PARP inhibitors, and PSMA radioligand therapy yields deeper initial control but creates heavily pretreated mCRPC with complex resistance and cumulative toxicity ...

A proof-of-concept study shows that cancer-linked RNA can be detected in wastewater, raising the possibility of tracking colorectal cancer patterns across communities without relying on individual ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...